Winter Conference

Annual Aspirus Heart & Vascular Winter Conference

The Winter Conference is an annual education event offered by Aspirus Heart & Vascular. It is held at the Westwood Conference Center in Wausau. This educational event covers a wide variety of topics related to heart care and heart health. Topics are presented by experts from Aspirus and throughout the country. The event is free for Aspirus employees and affiliates.

The Winter Conference will not be held in 2021.

Conference Details

  • Details for the next Winter Conference will be posted when they become available.

Intended Audience

This conference is intended for cardiologists, general internists, family practice physicians, nurse practitioners, physician assistants, pharmacists, registered nurses, exercise physiologists, rehabilitation professionals, trainees in medicine and other specialists interested in cardiovascular risk factors and treatment options.

Learning Objectives

At the completion of this activity, participants will be able to:

  • Define the pathophysiology and progressive nature of diabetes.
  • List risk factors that contribute to metabolic syndrome and diabetes.
  • Review new approaches to diabetes management using currently available diabetes medications.
  • Describe diabetes management strategies to address microvascular and macrovascular complications.
  • Discuss non-pharmacological therapies to facilitate weight loss.
  • Review recommendations for maintaining weight loss.
  • Describe similarities and differences of oral diabetes medication treatment options.
  • Review side effect profiles of traditional oral diabetes medications.
  • Discuss guideline recommendations for GLP-1 agonist therapy initiation.
  • Review GLP-1 agonist effects on glycemic control, cardiovascular outcomes, and weight loss.
  • Describe which patients may benefit most from insulin therapy.
  • Review the role of insulin in a management algorithm.
  • Discuss available insulin products and how to best utilize therapy.
  • Review clinical trial data on cardiovascular outcomes with use of the SGLT-2 inhibitors.
  • Discuss the appropriate use and side effect profiles of SGLT-2 inhibitors.
  • Recognize strategies for managing complex patients with diabetes and other co-morbidities.